Pages that link to "Q36948933"

The following pages link to Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment (Q36948933):

Displaying 46 items.

• The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences (Q26741938) (← links)
• Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response (Q26772028) (← links)
• The genetics of multiple sclerosis: review of current and emerging candidates (Q26825782) (← links)
• Epigenetic Drugs for Multiple Sclerosis (Q28076395) (← links)
• Biomarkers of mercury exposure in the Amazon (Q33609085) (← links)
• Swimming exercise ameliorates multiple sclerosis-induced impairment of short-term memory by suppressing apoptosis in the hippocampus of rats (Q33629854) (← links)
• A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide (Q34074496) (← links)
• Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis (Q35101760) (← links)
• Glycogen synthase kinase-3 controls IL-10 expression in CD4( ) effector T-cell subsets through epigenetic modification of the IL-10 promoter (Q35509305) (← links)
• Genetic determinants of risk and progression in multiple sclerosis (Q35915818) (← links)
• Repetitive element hypermethylation in multiple sclerosis patients. (Q36055884) (← links)
• Multiple sclerosis: getting personal with induced pluripotent stem cells (Q36293848) (← links)
• Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation (Q37056269) (← links)
• Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches (Q37548170) (← links)
• Recent progress in omics-driven analysis of MS to unravel pathological mechanisms (Q38140023) (← links)
• Epigenetics of multiple sclerosis: an updated review (Q38197927) (← links)
• Epigenetic drug discovery for Alzheimer's disease (Q38225708) (← links)
• Oligodendroglial Development: New Roles for Chromatin Accessibility. (Q38309342) (← links)
• Schwann cell myelination (Q38520894) (← links)
• The epigenetics of aging and neurodegeneration. (Q38527233) (← links)
• DNA methylation in demyelinated multiple sclerosis hippocampus (Q38617952) (← links)
• Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view (Q38682574) (← links)
• Expression and regulation of human endogenous retrovirus W elements. (Q38714222) (← links)
• Further understanding of the immunopathology of multiple sclerosis: impact on future treatments (Q38837294) (← links)
• Epigenetic Modifications and Therapy in Multiple Sclerosis. (Q38887611) (← links)
• Degron protease blockade sensor to image epigenetic histone protein methylation in cells and living animals. (Q38930681) (← links)
• Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA. (Q39288872) (← links)
• The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson (Q40508720) (← links)
• The genetics of multiple sclerosis in Latin America (Q41847281) (← links)
• Promoting return of function in multiple sclerosis: An integrated approach (Q41872258) (← links)
• MiR-126: a novel route for natalizumab action? (Q42233577) (← links)
• Epigenetic modifications in brain and immune cells of multiple sclerosis patients (Q47880039) (← links)
• Molecular Genetic and Epigenetic Basis of Multiple Sclerosis (Q48354362) (← links)
• Smoking at time of CIS increases the risk of clinically definite multiple sclerosis (Q49722846) (← links)
• Polyautoimmunity in a Greek cohort of multiple sclerosis. (Q51109980) (← links)
• The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency. (Q52312695) (← links)
• Methylation differences at the HLA-DRB1 locus in CD4 T-Cells are associated with multiple sclerosis. (Q54443135) (← links)
• The tale of histone modifications and its role in multiple sclerosis. (Q55497360) (← links)
• Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders? (Q57898104) (← links)
• Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases (Q58555658) (← links)
• Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis (Q58775742) (← links)
• Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1 (Q61135547) (← links)
• The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis (Q64065809) (← links)
• Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics (Q85263415) (← links)
• Environmental Influencers, MicroRNA, and Multiple Sclerosis (Q89493546) (← links)
• Peripheral nerve injury and myelination: Potential therapeutic strategies (Q90683634) (← links)